As of May 2024 Maravai LifeSciences has a market cap of $2.65 Billion. This makes Maravai LifeSciences the world's 3710th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.65 B | 61.17% |
2023 | $1.64 B | -54.93% |
2022 | $3.65 B | -33.7% |
2021 | $5.50 B | 103.18% |
2020 | $2.71 B |
On May 14th, 2024 the market cap of Maravai LifeSciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $11.31 M | -99.57% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -85.67% | ๐ฌ๐ง UK |
Novavax NVAX | $1.98 B | -25.15% | ๐บ๐ธ USA |
Novocure
NVCR | $2.18 B | -17.57% | Jersey |